| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $7.92B | +13.3% |
| Cost of Revenue | $5.62B | +10.0% |
| Gross Profit | $2.30B | +22.5% |
| R&D Expense | $29.0M | +26.6% |
| SG&A Expense | $1.33B | +23.4% |
| Operating Income | $793.5M | +32.5% |
| Interest Expense | $316.5M | +13.4% |
| Pre-tax Income | $472.1M | +14.3% |
| Income Tax | $105.1M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $787.4M | +743.9% |
| Accounts Receivable | $582.9M | +13.8% |
| Inventory | $754.2M | -4.5% |
| Current Assets | $2.23B | +50.9% |
| Total Assets | $12.85B | +10.4% |
| Current Liabilities | $944.9M | +17.3% |
| Long-term Debt | $6.81B | +12.8% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $931.7M | +24.2% |
| Investing Cash Flow | -$677.5M | -1.2% |
| Financing Cash Flow | $415.6M | +174.8% |
| +5.4% |
| Net Income | $366.7M | +21.7% |
| EPS (Basic) | $6.12 | +17.5% |
| EPS (Diluted) | $5.64 | +17.0% |
| Total Liabilities |
| $8.75B |
| +12.3% |
| Stockholders' Equity | $4.09B | +6.5% |